Preserving fluid and application thereof

A preservation solution, aminolevulinic acid technology, applied in the field of biology, can solve problems such as failure to achieve, limit organ safety time, increase the risk of organ damage, etc., achieve high cell survival rate, reduce mitochondrial damage, and reduce ischemia Effects of reperfusion injury
CN114052008APending Publication Date: 2022-02-18THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
Publication Date
2022-02-18

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a preserving fluid. The preserving fluid is prepared from one or a mixture of more than two of 5-aminolevulinic acid, L-carnosine, L-glutamic acid and D-biotin. The invention also discloses an application of the preserving fluid. Compared with the prior art, the 5-aminolevulinic acid, the L-carnosine, the L-glutamic acid and the D-biotin are added into the preserving fluid, cells, tissues and / or organs are subjected to cold preservation, the cell survival rate is high, cell apoptosis caused by cold preservation-rewarming can be effectively reduced, mitochondrial membrane potential can be stabilized, mitochondria can be prevented from excessively generating reactive oxygen free radicals, mitochondrial injury caused by cold preservation-rewarming can be effectively reduced, accordingly, ischemia reperfusion injury of donation tissues and organs in transplantation procedures can be reduced, and the preserving fluid has great significance in progress of organ transplantation preservation technologies.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of biology, in particular to a preservation solution for keeping cells alive without blood supply, reducing in vitro preservation damage, and promoting the recovery of tissues and organs, and the application of the preservation solution. Background technique

[0002] As early as the 20th century, there were the first organ transplants. Organ transplantation is to place a healthy organ into a critically ill patient through surgery or other methods, so that the organ can continue to function, so that the organ recipient can be reborn. For resected healthy organs, it is necessary to perfuse and impregnate them with preservation solution, so as to prevent organ necrosis and ischemia-reperfusion injury. The so-called ischemia-reperfusion refers to the reperfusion of an organ or tissue in an ischemic state, causing various toxic substances to be produced in the microcirculation of the organ or tissue, thereby cau...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More